Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients. (Q50853922)
Jump to navigation
Jump to search
scientific article published in August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients. |
scientific article published in August 2014 |
Statements
1 reference
Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients. (English)
1 reference
A Busch
1 reference
D Zeh
1 reference
V Janzen
1 reference
L-O Mügge
1 reference
D Wolf
1 reference
L Fingerhut
1 reference
C Hahn-Ast
1 reference
O Maurer
1 reference
P Brossart
1 reference
M von Lilienfeld-Toal
1 reference
1 August 2014
1 reference
177
1 reference
439-453
1 reference
2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference